Leucadia National - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 327 filers reported holding ROYALTY PHARMA PLC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.

Quarter-by-quarter ownership
Leucadia National ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$635,076
-82.6%
23,400
-85.7%
0.01%
-81.8%
Q2 2023$3,649,760
+281.9%
163,730
+128.9%
0.03%
+312.5%
Q1 2023$955,804
-25.1%
71,528
+51.3%
0.01%
-11.1%
Q4 2022$1,275,62747,2780.01%
Other shareholders
ROYALTY PHARMA PLC shareholders Q1 2023
NameSharesValueWeighting ↓
SIGULER GUFF ADVISERS, LLC 3,391,754$134,04264.43%
Vantage Consulting Group Inc 1,022,194$35,462,04720.94%
Indie Asset Partners, LLC 462,000$18,258,24020.01%
Silicon Valley Community Foundation 1,032,320$40,797,2867.84%
Overbrook Management Corp 609,352$24,081,5917.00%
Renaissance Capital LLC 137,462$5,432,4984.24%
Geo Capital Gestora de Recursos Ltd 124,090$4,9043.92%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,974,625$78,037,1803.28%
Lagoda Investment Management, L.P. 119,080$4,706,0423.18%
VIKING GLOBAL INVESTORS LP 10,008,511$395,536,3551.98%
View complete list of ROYALTY PHARMA PLC shareholders